World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
123
Citations
71793
World Ranking
3293
National Ranking
1815

Overview

Peter S. Nelson is affiliated with the Fred Hutchinson Cancer Research Center in the United States. Their research focuses predominantly on medicine, with significant contributions to biochemistry, genetics, and molecular biology. Subfields of their work include pulmonary and respiratory medicine, molecular biology, oncology, cancer research, and radiology, nuclear medicine, and imaging.

The main topics of Peter S. Nelson's research encompass prostate cancer treatment and research, prostate cancer diagnosis and treatment, radiopharmaceutical chemistry and applications, cancer, lipids, and metabolism, cancer genomics and diagnostics, PARP inhibition in cancer therapy, and ubiquitin and proteasome pathways.

Recent papers authored or co-authored by Peter S. Nelson include:

  • Genomic and phenotypic heterogeneity in prostate cancer, 2020, Nature Reviews Urology
  • TMPRSS2 and COVID-19: Serendipity or Opportunity for Intervention?, 2020, Cancer Discovery
  • In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo, 2020, Nature Communications
  • Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling, 2021, Nature Communications
  • Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress, 2020, Cell Reports

Frequent co-authors include:

  • Ilsa M. Coleman
  • Eva Corey
  • Michael C. Haffner
  • Colm Morrissey
  • Bruce Montgomery

Peter S. Nelson's publications frequently appear in these venues:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Clinical Oncology
  • The Prostate
  • Cancer Research
  • Nature Communications

Best Publications

  • Circulating microRNAs as stable blood-based markers for cancer detection

    Patrick S. Mitchell;Rachael K. Parkin;Evan M. Kroh;Brian R. Fritz;Brian R. Fritz

  • Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor

    Jean-Philippe Coppe;Christopher K Patil;Francis Rodier;Francis Rodier;Yun-Yu Sun

  • Integrative clinical genomics of advanced prostate cancer

    Dan Robinson;Eliezer M. Van Allen;Eliezer M. Van Allen;Yi Mi Wu;Nikolaus Schultz

  • The Molecular Taxonomy of Primary Prostate Cancer

    Adam Abeshouse;Jaeil Ahn;Rehan Akbani;Adrian Ally

  • Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

    Christopher E. Barbieri;Sylvan C. Baca;Sylvan C. Baca;Michael S. Lawrence;Francesca Demichelis;Francesca Demichelis

  • Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth

    R. Bruce Montgomery;Elahe A. Mostaghel;Robert Vessella;David L. Hess

  • Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

    Colin C. Pritchard;Joaquin Mateo;Michael F. Walsh;Navonil De Sarkar

  • Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

    Howard I. Scher;Michael J. Morris;Walter M. Stadler;Celestia Higano

  • Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer

    Shunyou Wang;Jing Gao;Qunying Lei;Nora Rozengurt

  • Genomic correlates of clinical outcome in advanced prostate cancer.

    Wassim Abida;Joanna Cyrta;Joanna Cyrta;Glenn Heller;Davide Prandi

  • MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation

    Remi Martin Laberge;Yu Sun;Arturo V. Orjalo;Christopher K. Patil

  • Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion

    William P Harris;Elahe A Mostaghel;Peter S Nelson;Bruce Montgomery

  • Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant

    Shihua Sun;Cynthia C.T. Sprenger;Robert L. Vessella;Kathleen Haugk

  • Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B

    Yu Sun;Judith Campisi;Judith Campisi;Celestia Higano;Celestia Higano;Tomasz M Beer

  • The long tail of oncogenic drivers in prostate cancer

    Joshua Armenia;Stephanie A. M. Wankowicz;Stephanie A. M. Wankowicz;David Liu;David Liu;Jianjiong Gao

  • Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer

    Akash Kumar;Ilsa Coleman;Colm Morrissey;Xiaotun Zhang

  • Resistance to CYP17A1 inhibition with abiraterone in castration resistant prostate cancer: Induction of steroidogenesis and androgen receptor splice variants

    Elahe A. Mostaghel;Brett T. Marck;Stephen R. Plymate;Robert L. Vessella

  • Prostate-localized and Androgen-regulated Expression of the Membrane-bound Serine Protease TMPRSS2

    Biaoyang Lin;Camari Ferguson;James T. White;Shunyou Wang

  • Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer

    Rong Hu;Changxue Lu;Elahe A. Mostaghel;Srinivasan Yegnasubramanian

  • The Molecular Taxonomy of Primary Prostate Cancer

    Adam Abeshouse;Jaeil Ahn;Rehan Akbani;Adrian Ally

Frequent Co-Authors

Lawrence D. True
Lawrence D. True University of Washington
Robert L. Vessella
Robert L. Vessella University of Washington
Daniel W. Lin
Daniel W. Lin University of Washington
Stephen R. Plymate
Stephen R. Plymate University of Washington
Celestia S. Higano
Celestia S. Higano University of Washington
Martin E. Gleave
Martin E. Gleave University of British Columbia
Paul H. Lange
Paul H. Lange University of Washington
Colin C. Pritchard
Colin C. Pritchard University of Washington
Mary-Ellen Taplin
Mary-Ellen Taplin Harvard University
James D. Brooks
James D. Brooks Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the education needed to study Medicine in the USA can open doors to a wide variety of online degrees and career pathways in healthcare. Many students consider advancing their qualifications through specialized programs and flexible study options.

For those interested in mental health, earning a fastest post master's pmhnp can lead to roles as a psychiatric nurse practitioner, helping address the growing demand for mental health services. Alternatively, healthcare management is a popular pathway—if you’re mindful of expenses, comparing healthcare administration degree cost is key to finding a quality and affordable option.

For postgraduate study, there are excellent affordable online mha programs available, as well as pathways to the highest degree in nursing. Choosing the cheapest dnp can help minimize debt while maximizing career advancement.

Whether you’re interested in clinical roles or healthcare leadership, these online degrees offer flexible, practical pathways to a rewarding medical career in the USA.

Best Scientists Citing Peter S. Nelson

Trending Scientists